The absence of ALG9 in the ADPKD patient’s cyst wall lining suggests that the progression of liver cyst growth in ADPLD patients is different than in ADPKD patients, and that this progression in ADPLD is due to a molecular mechanism that requires high levels of ALG9. The gene discussed is ALG9; the disease is autosomal dominant polycystic liver disease.